Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Original Articles

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial

Pinkerton, JoAnn V. MD1; Constantine, Ginger MD2; Hwang, Eunhee PhD3; Cheng, Ru-fong J. MD3for the Study 3353 Investigators

Author Information
Menopause: The Journal of The North American Menopause Society: January 2013 - Volume 20 - Issue 1 - p 28-37
doi: 10.1097/gme.0b013e31826421a8
  • Buy
  • SDC

© 2013 by The North American Menopause Society.